What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries
| Autor: | Boels, A.M., Vos, R.C., Hermans, T.G.T., Zuithoff, N.P.A., Muller, N., Khunti, K., Rutten, G.E.H.M., GUIDANCE Study Grp |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Male
insulin Pediatrics medicine.medical_specialty type 2 diabetes mellitus Cross-sectional study Health Status DTSQ medicine.medical_treatment Type 2 Europe Female Glycated Hemoglobin A Health Status Humans Hypoglycemic Agents Insulin Male Middle Aged Patient Satisfaction Quality of Life Surveys and Questionnaires DTSQ diabetes education general diabetes insulin treatment satisfaction type 2 diabetes mellitus 030209 endocrinology & metabolism Type 2 diabetes treatment satisfaction Treatment satisfaction 03 medical and health sciences 0302 clinical medicine Patient satisfaction Quality of life Surveys and Questionnaires medicine Journal Article Humans Hypoglycemic Agents 030212 general & internal medicine AgedCross-Sectional Studies Diabetes Mellitus Aged Glycated Hemoglobin business.industry AgedCross-Sectional Studies Diabetes Mellitus Type 2 Europe Female Glycated Hemoglobin A Health Status Humans Hypoglycemic Agents Insulin Male Middle Aged Patient Satisfaction Quality of Life Surveys and Questionnaires DTSQ diabetes education general diabetes insulin treatment satisfaction type 2 diabetes mellitus Research general diabetes Insulin diabetes education Type 2 Diabetes Mellitus General Medicine Middle Aged medicine.disease Europe Diabetes and Endocrinology Cross-Sectional Studies Diabetes Mellitus Type 2 Patient Satisfaction Quality of Life Female Observational study business |
| Zdroj: | BMJ Open, 7(7), e016180 BMJ open [E], 7(7). BMJ Publishing Group BMJ Open |
| ISSN: | 2044-6055 |
| Popis: | Objective Patients with type 2 diabetes (T2DM) on insulin therapy are less satisfied with their diabetes treatment than those on oral hypoglycaemic therapies or lifestyle advice only. Determinants of satisfaction in patients with T2DM on insulin therapy are not clearly known. The aim of this study was to determine the association of treatment satisfaction with demographic and clinical characteristics of patients with T2DM. Design For this study we used data from the GUIDANCE (Guideline Adherence to Enhance Care) study, a cross-sectional study among 7597 patients with T2DM patients from Belgium, France, Germany, Ireland, Italy, Sweden, the Netherlands and the UK. The majority of patients were recruited from primary care. Treatment satisfaction was assessed by the Diabetes Treatment Satisfaction Questionnaire (DTSQ, score 0–36; higher scores reflecting higher satisfaction). To determine which patient characteristics and laboratory values were independently associated with treatment satisfaction, a linear mixed model analysis was used. Participants In total, 1984 patients on insulin were analysed; the number of included patients per country ranged from 166 (the Netherlands) to 384 (Italy). Results The mean DTSQ score was 28.50±7.52 and ranged from 25.93±6.57 (France) to 30.11±5.09 (the Netherlands). Higher DTSQ scores were associated with having received diabetes education (β 1.64, 95% CI 0.95 to 2.32), presence of macrovascular complications (β 0.76, 95% CI 0.21 to 1.31) and better health status (β 0.08 for every one unit increase on a 0–100 scale, 95% CI 0.07 to 0.10). Lower DTSQ scores were associated with more frequently perceived hyperglycaemia (β −0.32 for every 1 unit increase on a seven-point Likert scale, 95% CI −0.50 to −0.13), and higher glycated haemoglobin (β −0.52 for every percentage increase, 95% CI −0.75 to −0.29). Conclusions A number of factors including diabetes education, perceived and actual hyperglycaemia and macrovascular complications are associated with treatment satisfaction. Self-management education programmes should incorporate these factors for ongoing support in patients with T2DM. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|